Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

Shah Gilani

Research Services- Money Morning - Only the News You Can Profit From.

  • Capital Wave Forecast

    As massive amounts of capital move in and out of asset classes faster than ever before, Shah shows you exactly how to ride these “capital waves” to profits.

    Learn more
  • Short-Side Fortunes

    Hedge fund legend Shah Gilani's newest research service lets you work "the other side of the trade," where the money you can make is off-the-charts crazy. For those willing to break the old "buy and hold" rule, Short-Side Fortunes opens up a whole new world of investing that will allow you to make huge money when asset classes flip direction – no matter which way they turn.

    Learn more